Literature DB >> 7212485

Aspects of the management of shock.

K I Shine, M Kuhn, L S Young, J H Tillisch.   

Abstract

Shock is a state of systemic imbalance between supply and demand for oxygenated blood. We discuss here management of shock states not primarily of cardiac origin. Inadequacy or maldistribution of blood volume is important in the pathogenesis of most forms of shock. The Military Anti-Shock Trouser (MAST) suit assists the redistribution of blood from the periphery to the central circulation. Normal saline and Ringer's lactate solution may be used interchangeably for acute volume replacement. Colloid replacement requires smaller volumes but carries a higher risk of pulmonary edema, whereas crystalloid replacement requires larger volumes and leads to more systemic edema. Myocardial injury may contribute notably to the transition from reversible to irreversible shock. Naloxone, lidocaine, and indomethacin have improved survival in animal models of endotoxin shock, but proof of efficacy in humans is lacking. A role for corticosteroid administration in shock remains to be defined. Effective antibiotic therapy is the best treatment for septic shock; antisera against endotoxic antigens may develop as important adjunctive therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7212485     DOI: 10.7326/0003-4819-93-5-723

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  7 in total

Review 1.  Accident and emergency medicine--II.

Authors:  R C Evans; R J Evans
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

Review 2.  Corticosteroids, nonsteroidal anti-inflammatory drugs, and naloxone in the sepsis syndrome.

Authors:  W M Long; C L Sprung
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

Review 3.  Vasodilators in acute circulatory failure.

Authors:  C Blakeley; J Tinker
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

4.  Ocular albumin fluorophotometric quantitation of endotoxin-induced vascular permeability.

Authors:  S W Cousins; J T Rosenbaum; R B Guss; P R Egbert
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

5.  Haemodynamic interventions and therapy in septic shock.

Authors:  T E Smith; P Forgacs
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

6.  Elevated intra-abdominal pressure and renal function.

Authors:  P K Harman; I L Kron; H D McLachlan; A E Freedlender; S P Nolan
Journal:  Ann Surg       Date:  1982-11       Impact factor: 12.969

7.  The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors.

Authors:  I C Kettelhut; W Fiers; A L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.